Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3
The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA4 | P22748 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Lactic Acid SCHEMBL503900 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL5013207 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL1292751 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL29655228 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL191421 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL29508771 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL25270068 | 0.93 | — | — | |
| L-Lactic Acid SCHEMBL407161 | 0.93 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL8462013 | 0.93 | — | — | |
| L-Lactic Acid SCHEMBL14119668 | 0.93 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016976-A1 | METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS | Zetagen Therapeutics, Inc. (US) | 2024-01-18 | — | — | US | claimed |
| US-20240000996-A1 | METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS | Zetagen Therapeutics, Inc. (US) | 2024-01-04 | — | — | US | claimed |
| CN-113913016-B | Polyarylethersulfone composition and preparation method and application thereof | 金发科技股份有限公司 | 2023-10-03 | — | — | CN | claimed |
| EP-4181981-A1 | METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS | Zetagen Therapeutics, Inc. (US) | 2023-05-24 | — | — | EP | claimed |
| CN-113831535-B | Preparation method of polyarylethersulfone resin, obtained polyarylethersulfone resin and application | 金发科技股份有限公司 | 2023-05-16 | — | — | CN | claimed |
| US-11254779-B1 | Reworkable ionomers | HRL LABORATORIES, LLC (US) | 2022-02-22 | — | — | US | claimed |
| WO-2022015364-A1 | METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS | Zetagen Therapeutics, Inc. (US) | 2022-01-20 | — | — | WO | claimed |
| CN-113913016-A | Polyarylethersulfone composition and preparation method and application thereof | 金发科技股份有限公司 | 2022-01-11 | — | — | CN | claimed |
| CN-113831535-A | Preparation method of polyarylethersulfone resin, polyarylethersulfone resin obtained by preparation method and application of polyarylethersulfone resin | 金发科技股份有限公司 | 2021-12-24 | — | — | CN | claimed |
| US-20260092381-A1 | BIMETALLIC IRON-VANADIUM OXIDE ELECTROCATALYST FOR OXYGEN EVOLUTION REACTION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-04-02 | — | — | US | disclosed |
| US-20260047581-A1 | BIODERIVED FERROMAGNETIC NICKEL-FERRITE (NiFe2O4) NANOPARTICLES | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-02-19 | — | — | US | disclosed |
| US-20260001777-A1 | BIODERIVED FERROMAGNETIC COBALT-FERRITE (CoFe2O4) NANOPARTICLES | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-01-01 | — | — | US | disclosed |
| US-20250352936-A1 | 3D-TRIPTYCENE-BASED MICROPOROUS POLYMER WITH HYDROXYL GROUPS FOR CARBON DIOXIDE CAPTURE AND METHODS OF PREPARATION THEREOF | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-20 | — | — | US | disclosed |
| US-20250352693-A1 | COMPOSITIONS USING IRON EXCIPIENTS AND THEIR USES INCLUDING FOR THE TREATMENT OF CANCER | Zetagen Therapeutics, Inc. (US) | 2025-11-20 | — | — | US | disclosed |
| US-20080032047-A1 | PARTICLES AND INKS AND FILMS USING THEM | CITIBANK, N.A. | 2008-02-07 | — | — | US | disclosed |
| WO-2008017062-A1 | PARTICLES AND INKS AND FILMS USING THEM | FRY'S METALS, INC. (US) | 2008-02-07 | — | — | WO | disclosed |
| EP-1876261-A1 | Electroless copper and redox couples | Rohm and Haas Electronic Materials, L.L.C. (US) | 2008-01-09 | — | — | EP | disclosed |
| WO-2007036291-A2 | IMPROVED CELL CULTURE MEDIUM | CELLCA GMBH (DE) | 2007-04-05 | — | — | WO | disclosed |
| EP-1704057-A1 | LASER IMAGING | Sherwood Technology LTD. (GB) | 2006-09-27 | — | — | EP | disclosed |
| WO-2005068207-A1 | LASER IMAGING | DATALASE LTD. (GB) | 2005-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092381-A1 | BIMETALLIC IRON-VANADIUM OXIDE ELECTROCATALYST FOR OXYGEN EVOLUTION REACTION | FECH, MFAP1, AP2S1 | TP53 1882/4885CA1 1108/4885CA4 1405/4885 |
| US-20260047581-A1 | BIODERIVED FERROMAGNETIC NICKEL-FERRITE (NiFe2O4) NANOPARTICLES | NIT2, NFE2, AIFM2 | TP53 4319/4885CA1 498/4885CA4 97/4885 |
| US-20260001777-A1 | BIODERIVED FERROMAGNETIC COBALT-FERRITE (CoFe2O4) NANOPARTICLES | CFL1, AIFM2, YAP1 | TP53 4635/4885CA1 89/4885CA4 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.